Helicobacter pylori sero-prevalence in different liver diseases

Tamer E. Mosa; Hatim A. El-Baz; Magda S. Mahmoud; Mahmoud EL-Sherbiny; Ahlam H. Mahmoud; Mostafa M. Abo-Zeid; Attallah A. M.

doi:10.5897/IJMMS12.147

International Journal of
Medicine and Medical Sciences

Abbreviation: Int. J. Med. Med. Sci.
Language: English
ISSN: 2006-9723
DOI: 10.5897/IJMMS
Start Year: 2009
Published Articles: 534

Full Length Research Paper

Helicobacter pylori sero-prevalence in different liver diseases

Tamer E. Mosa

Tamer E. Mosa
Biochemistry Department, Genetic Engineering and Biotechnology Division, National Research Centre, Egypt.
Search for this author on:
Google Scholar

Hatim A. El-Baz

Hatim A. El-Baz
Biochemistry Department, Genetic Engineering and Biotechnology Division, National Research Centre, Egypt.
Search for this author on:
Google Scholar

Magda S. Mahmoud

Magda S. Mahmoud
Biochemistry Department, Genetic Engineering and Biotechnology Division, National Research Centre, Egypt.
Search for this author on:
Google Scholar

Mahmoud EL-Sherbiny

Mahmoud EL-Sherbiny
Therapeutical Chemistry Department, National Research Centre, Egypt.
Search for this author on:
Google Scholar

Ahlam H. Mahmoud

Ahlam H. Mahmoud
Therapeutical Chemistry Department, National Research Centre, Egypt.
Search for this author on:
Google Scholar

Mostafa M. Abo-Zeid

Mostafa M. Abo-Zeid
Gastroenterology center, Mansoura University.
Search for this author on:
Google Scholar

Attallah A. M.

Attallah A. M.
Biotechnology Research Center, New Damietta City, Egypt.
Search for this author on:
Google Scholar

Article Number - F19EF5B15
Vol.5(9), pp. 414-419 , September 2013
https://doi.org/10.5897/IJMMS12.147

Accepted: 22 July 2013
Published: 01 September 2013

Abstract

This study was carried out to investigate the seroprevalence of Helicobacter pylori infection in patients with different liver diseases and determine the association and correlation between the seroprevalence of H. pylori infection and the liver diseases. The presence of a H. pylori antigen was investigated in serum samples from 274 individuals with liver diseases as well as 120 healthy individuals. H. pylori antigen was detected using enzyme-linked immunosorbent assay (ELISA) and Western blot based on specific anti-H. pylori antibody. The result was analyzed using the chi-square test. H. pylori was detected in sera samples of 31.7% (20/63) (X²= 3.7) of non-cirrhotic, 50% (11/22) (X²= 3.9) of cirrhotic and 56.1% (106/189) (X²= 5.2) of hepatocellular carcinoma (HCC) individuals, compared to 8.4% (10/120) of healthy individuals. The levels of H. pyloriantigen were significantly higher (p < 0.05) in sera of different stages of liver diseases compared by healthy individuals. We found a good correlation between H. pylori antigen levels and the severity of the liver diseases (Pathology) (r = 0.368, p < 0.001). Also, there is a correlation between age and H. pylori antigen levels (r = 0.25, p < 0.001). H. pylori infection is correlated with occurrence and development of different stages of liver diseases.